Literature DB >> 1968211

Risk estimates for screening adenomatous polyposis coli.

R Houlston, J Slack, V Murday.   

Abstract

Entities:  

Mesh：

Year:  1990        PMID： 1968211     DOI： 10.1016/0140-6736(90)90724-j

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  The use of DNA from paraffin wax preserved tissue for predictive diagnosis in familial adenomatous polyposis.

Authors:  D G Morton; F Macdonald; M B Cachon-Gonzales; P M Rindl; J P Neoptolemos; M R Keighley; J D Delhanty; C M McKeown; M Kilpatrick; M A Hultén
Journal:  J Med Genet       Date:  1992-08       Impact factor: 6.318

2.  Risk estimation in familial adenomatous polyposis using DNA probes linked to the familial adenomatous polyposis gene.

Authors:  D J Koorey; G W McCaughan; R J Trent; N D Gallagher
Journal:  Gut       Date:  1992-04       Impact factor: 23.059

Review 3.  Overview of screening and management of familial adenomatous polyposis.

Authors:  M Rhodes; D M Bradburn
Journal:  Gut       Date:  1992-01       Impact factor: 23.059

4.  Familial adenomatous polyposis: more evidence for disease diversity and genetic heterogeneity.

Authors:  R J Scott; C Meldrum; R Crooks; A D Spigelman; J Kirk; K Tucker; D Koorey
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

5.  The UK Northern region genetic register for familial adenomatous polyposis coli: use of age of onset, congenital hypertrophy of the retinal pigment epithelium, and DNA markers in risk calculations.

Authors:  J Burn; P Chapman; J Delhanty; C Wood; F Lalloo; M B Cachon-Gonzalez; K Tsioupra; W Church; M Rhodes; A Gunn
Journal:  J Med Genet       Date:  1991-05       Impact factor: 6.318
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.